BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7904107)

  • 1. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks.
    Faergemann J; Zehender H; Denouël J; Millerioux L
    Acta Derm Venereol; 1993 Aug; 73(4):305-9. PubMed ID: 7904107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days.
    Faergemann J; Zehender H; Millerioux L
    Clin Exp Dermatol; 1994 Mar; 19(2):121-6. PubMed ID: 8050139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat.
    Faergemann J; Zehender H; Jones T; Maibach I
    Acta Derm Venereol; 1991; 71(4):322-6. PubMed ID: 1681649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.
    Kovarik JM; Mueller EA; Zehender H; Denouël J; Caplain H; Millerioux L
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2738-41. PubMed ID: 8593011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication.
    Faergemann J; Zehender H; Boukhabza A; Smith SG; Jones TC
    Acta Derm Venereol; 1997 Jan; 77(1):74-6. PubMed ID: 9059688
    [No Abstract]   [Full Text] [Related]  

  • 6. Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat.
    Faergemann J; Laufen H
    Clin Exp Dermatol; 1993 Mar; 18(2):102-6. PubMed ID: 8481982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracutaneous transport of orally administered fluconazole to the stratum corneum.
    Faergemann J; Godleski J; Laufen H; Liss RH
    Acta Derm Venereol; 1995 Sep; 75(5):361-3. PubMed ID: 8615052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fluconazole in skin and nails.
    Faergemann J
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S14-20. PubMed ID: 10367911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% cream.
    Hill S; Thomas R; Smith SG; Finlay AY
    Br J Dermatol; 1992 Oct; 127(4):396-400. PubMed ID: 1419761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally administered ketoconazole: route of delivery to the human stratum corneum.
    Harris R; Jones HE; Artis WM
    Antimicrob Agents Chemother; 1983 Dec; 24(6):876-82. PubMed ID: 6318663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of persistence of terbinafine in the hair of normal cats after 14 days of daily therapy.
    Foust AL; Marsella R; Akucewich LH; Kunkle G; Stern A; Moattari S; Szabo NJ
    Vet Dermatol; 2007 Aug; 18(4):246-51. PubMed ID: 17610490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses.
    Kienzler JL; Queille-Roussel C; Mugglestone C; Ortonne JP; Larnier C
    Curr Med Res Opin; 2007 Jun; 23(6):1293-302. PubMed ID: 17559730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of fluconazole in the skin after oral medication.
    Wildfeuer A; Faergemann J; Laufen H; Pfaff G; Zimmermann T; Seidl HP; Lach P
    Mycoses; 1994; 37(3-4):127-30. PubMed ID: 7845418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luliconazole Retention in Stratum Corneum and Prevention of Fungal Infection in a Guinea Pig Tinea Pedis Model.
    Koga H; Nanjoh Y; Toga T; Pillai R; Jo W; Tsuboi R
    J Drugs Dermatol; 2016 Jan; 15(1):104-8. PubMed ID: 26741388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on antifungal therapy with terbinafine.
    Gianni C
    G Ital Dermatol Venereol; 2010 Jun; 145(3):415-24. PubMed ID: 20461049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined use of oral and topical lipophilic antioxidants increases their levels both in sebum and stratum corneum.
    Passi S; De Pità O; Grandinetti M; Simotti C; Littarru GP
    Biofactors; 2003; 18(1-4):289-97. PubMed ID: 14695946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug testing with alternative matrices I. Pharmacological effects and disposition of cocaine and codeine in plasma, sebum, and stratum corneum.
    Joseph RE; Oyler JM; Wstadik AT; Ohuoha C; Cone EJ
    J Anal Toxicol; 1998; 22(1):6-17. PubMed ID: 9491963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terbinafine: an oral and topical antifungal agent.
    Shear NH; Villars VV; Marsolais C
    Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
    [No Abstract]   [Full Text] [Related]  

  • 19. Determining canine skin concentrations of terbinafine to guide the treatment of Malassezia dermatitis.
    Gimmler JR; White AG; Kennis RA; Cruz-Espindola C; Boothe DM
    Vet Dermatol; 2015 Dec; 26(6):411-6, e95-6. PubMed ID: 26286855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream.
    Saeheng S; Nosoongnoen W; Varothai S; Sathirakul K
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1372-7. PubMed ID: 23057672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.